Sustained release of tulobuterol from graphene oxide laden hydrogel to manage asthma

Volume: 32, Issue: 4, Pages: 524 - 535
Published: Dec 2, 2020
Abstract
Bronchial asthma is a chronic disease which is currently treated using various inhalants. However, the medication adherence with the inhalants is poor due to complex procedure to use them along with frequent dosing. In this paper, we have developed tulobuterol loaded Pluronic® F127-reduced graphene oxide transdermal hydrogel to sustain the release of tulobuterol to manage asthma for days. The synthesis of Pluronic® F127-reduced graphene oxide...
Paper Details
Title
Sustained release of tulobuterol from graphene oxide laden hydrogel to manage asthma
Published Date
Dec 2, 2020
Volume
32
Issue
4
Pages
524 - 535
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.